Delivery Order SPE2DR25D2010-SPE2DR26F4YWN
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,265.71 by the Defense Logistics Agency (DLA) for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, awarded on July 31, 2025, with completion targeted for August 1, 2025, represents a small-value pharmaceutical transaction under the company's broader contracting relationship with DLA. The contract involves no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,323.20 for Mounjaro 5 mg/0.5 ml pen injections on November 14, 2025, with completion scheduled for November 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,654.60 by the Defense Logistics Agency on November 14, 2025. The contract calls for delivery of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml units), a diabetes management medication, with an ultimate completion date of November 17, 2025. This delivery order utilizes firm fixed price pricing and was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency valued at $1,360.45 for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of July 21, 2025. The award was issued on July 18, 2025, under a firm fixed-price contract type with no set-aside designation, indicating competitive procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a $1,040.19 delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with an ultimate completion date of September 26, 2025, and represents performance at the company's Conshohocken, Pennsylvania headquarters. The award was competitively procured with no set-aside designation and serves as a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a $4,897.62 delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen (0.5 ml). This firm fixed-price contract, with an ultimate completion date of August 28, 2025, is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. Performance will be conducted at the...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.10 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on November 6, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitive award, valued at $7,167.84 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The ultimate completion date is set for September 23, 2025....
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 20, 2025, by the Defense Logistics Agency for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This competitively awarded, non-set-aside contract carries a ceiling value of $1,543.85 and is structured as a firm fixed price delivery order with an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4YWNDelivery Order
AmerisourceBergen Drug Corp was awarded a competitively procured delivery order valued at $25,328.00 by the Defense Logistics Agency (DLA) on November 10, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. The award is non-set-aside and carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order represents a routine pharmaceutical procurement action within the federal medical supply chain. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor under this master IDC, AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, supplying a broad portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to meet federal procurement requirements through competitive awards positions it as a key vendor for military healthcare support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 11/10/25 |